Trials / Completed
CompletedNCT00911365
Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
A Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is based on positive results in open label trial of mesenchymal stem cells therapy in patients with Multiple System Atrophy (MSA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | autologous mesenchymal stem cells | 4\*107 stem cell (100ml) Intra arterial infusion/ one time, then 4\*107 stem cell(100ml)Intravenous infusion 3 times/monthly -\> Total four times |
| BIOLOGICAL | normal saline | saline |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2009-06-01
- Last updated
- 2011-08-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00911365. Inclusion in this directory is not an endorsement.